CoChat

Artificial Intelligence Algorithms to Assess Hormonal Status From Tissue Microarrays in Patients With Breast Cancer

Open access
Shamai, Gil, Binenbaum, Yoav, Slossberg, Ron, Duek, Irit, Gil, Ziv, Kimmel, Ron · 2019 · JAMA Network Open
Cited by 133

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Importance: Immunohistochemistry (IHC) is the most widely used assay for identification of molecular biomarkers. However, IHC is time consuming and costly, depends on tissue-handling protocols, and relies on pathologists' subjective interpretation. Image analysis by machine learning is gaining ground for various applications in pathology but has not been proposed to replace chemical-based assays for molecular detection. Objective: To assess the prediction feasibility of molecular expression of biomarkers in cancer tissues, relying only on tissue architecture as seen in digitized hematoxylin-eosin (H&E)-stained specimens. Design, Setting, and Participants: This single-institution retrospective diagnostic study assessed the breast cancer tissue microarrays library of patients from Vancouver General Hospital, British Columbia, Canada. The study and analysis were conducted from July 1, 2015, through July 1, 2018. A machine learning method, termed morphological-based molecular profiling (MBMP), was developed. Logistic regression was used to explore correlations between histomorphology and biomarker expression, and a deep convolutional neural network was used to predict the biomarker expression in examined tissues. Main Outcomes and Measures: Positive predictive value (PPV), negative predictive value (NPV), and area under the receiver operating characteristics curve measures of MBMP for assessment of molecular biomarkers. Results: The database consisted of 20 600 digitized, publicly available H&E-stained sections of 5356 patients with breast cancer from 2 cohorts. The median age at diagnosis was 61 years for cohort 1 (412 patients) and 62 years for cohort 2 (4944 patients), and the median follow-up was 12.0 years and 12.4 years, respectively. Tissue histomorphology was significantly correlated with the molecular expression of all 19 biomarkers assayed, including estrogen receptor (ER), progesterone receptor (PR), and ERBB2 (formerly HER2). Expression of ER was predicted for 105 of 207 validation patients in cohort 1 (50.7%) and 1059 of 2046 validation patients in cohort 2 (51.8%), with PPVs of 97% and 98%, respectively, NPVs of 68% and 76%, respectively, and accuracy of 91% and 92%, respectively, which were noninferior to traditional IHC (PPV, 91%-98%; NPV, 51%-78%; and accuracy, 81%-90%). Diagnostic accuracy improved given more data. Morphological analysis of patients with ER-negative/PR-positive status by IHC revealed resemblance to patients with ER-positive status (Bhattacharyya distance, 0.03) and not those with ER-negative/PR-negative status (Bhattacharyya distance, 0.25). This suggests a false-negative IHC finding and warrants antihormonal therapy for these patients. Conclusions and Relevance: For at least half of the patients in this study, MBMP appeared to predict biomarker expression with noninferiority to IHC. Results suggest that prediction accuracy is likely to improve as data used for training expand. Morphological-based molecular profiling could be used as a general approach for mass-scale molecular profiling based on digitized H&E-stained images, allowing quick, accurate, and inexpensive methods for simultaneous profiling of multiple biomarkers in cancer tissues.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamanetworkopen.2019.7700

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 31

  1. Lin, 2014, Standardization of diagnostic immunohistochemistry: literature review and Geisinger experience., Arch Pathol Lab Med, 138, 1564, 10.5858/arpa.2014-0074-RA · DOI
  2. Gown, 2008, Current issues in ER and HER2 testing by IHC in breast cancer., Mod Pathol, 21, S8, 10.1038/modpathol.2008.34 · DOI · Paper page
  3. Robb, 2014, A call to standardize preanalytic data elements for biospecimens., Arch Pathol Lab Med, 138, 526, 10.5858/arpa.2013-0250-CP · doi:10.5858/arpa.2013-0250-cp
  4. Engel, 2011, Effects of preanalytical variables on the detection of proteins by immunohistochemistry in formalin-fixed, paraffin-embedded tissue., Arch Pathol Lab Med, 135, 537, 10.5858/2010-0702-RAIR.1 · DOI · Paper page
  5. Langer, 2015, Computer-aided diagnostics in digital pathology: automated evaluation of early-phase pancreatic cancer in mice., Int J Comput Assist Radiol Surg, 10, 1043, 10.1007/s11548-014-1122-9 · DOI
  6. Romo-Bucheli, 2017, A deep learning based strategy for identifying and associating mitotic activity with gene expression derived risk categories in estrogen receptor positive breast cancers., Cytometry A, 91, 566, 10.1002/cyto.a.v91.6 · doi:10.1002/cyto.a.v91.6
  7. Djuric, 2017, Precision histology: how deep learning is poised to revitalize histomorphology for personalized cancer care., NPJ Precis Oncol, 1, 22, 10.1038/s41698-017-0022-1 · DOI · Paper page
  8. Beck, 2011, Systematic analysis of breast cancer morphology uncovers stromal features associated with survival., Sci Transl Med, 3, 108ra113, 10.1126/scitranslmed.3002564 · DOI · Paper page
  9. Hammond, 2010, American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version)., Arch Pathol Lab Med, 134, e48, 10.5858/134.7.e48 · DOI · Paper page
  10. Troxell, 2017, Comparison of estrogen and progesterone receptor antibody reagents using proficiency testing data., Arch Pathol Lab Med, 141, 1402, 10.5858/arpa.2016-0497-OA · DOI
  11. Cheang, 2006, Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival., J Clin Oncol, 24, 5637, 10.1200/JCO.2005.05.4155 · DOI · Paper page
  12. Bogina, 2012, Comparison of anti-estrogen receptor antibodies SP1, 6F11, and 1D5 in breast cancer: lower 1D5 sensitivity but questionable clinical implications., Am J Clin Pathol, 138, 697, 10.1309/AJCPLX0QJROV2IJG · doi:10.1309/ajcplx0qjrov2ijg
  13. Tang, 2016, Immunohistochemical surrogates for molecular classification of breast carcinoma: a 2015 update., Arch Pathol Lab Med, 140, 806, 10.5858/arpa.2015-0133-RA · DOI
  14. Achanta, 2012, SLIC superpixels compared to state-of-the-art superpixel methods., IEEE Trans Pattern Anal Mach Intell, 34, 2274, 10.1109/TPAMI.2012.120 · DOI · Paper page
  15. Bhattacharyya, 1946, On a measure of divergence between two multinomial populations., Sankhya, 7, 401
  16. Marinelli, 2008, The Stanford tissue microarray database., Nucleic Acids Res, 36, D871
  17. Xing, 2014, Automatic Ki-67 counting using robust cell detection and online dictionary learning., IEEE Trans Biomed Eng, 61, 859, 10.1109/TBME.2013.2291703 · DOI · Paper page
  18. Saha, 2017, An advanced deep learning approach for Ki-67 stained hotspot detection and proliferation rate scoring for prognostic evaluation of breast cancer., Sci Rep, 7, 3213, 10.1038/s41598-017-03405-5 · DOI · Paper page
  19. Nadji, 2005, Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers., Am J Clin Pathol, 123, 21, 10.1309/4WV79N2GHJ3X1841 · doi:10.1309/4wv79n2ghj3x1841 · Paper page
  20. Barnes, 1996, Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients., Br J Cancer, 74, 1445, 10.1038/bjc.1996.563 · DOI · Paper page
  21. Regan, 2006, Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays., J Natl Cancer Inst, 98, 1571, 10.1093/jnci/djj415 · DOI · Paper page
  22. Harvey, 1999, Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer., J Clin Oncol, 17, 1474, 10.1200/JCO.1999.17.5.1474 · DOI · Paper page
  23. Bianchini, 2010, Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and-negative cancers., J Clin Oncol, 28, 4316, 10.1200/JCO.2009.27.2419 · DOI · Paper page
  24. Haslam, 2003, Host microenvironment in breast cancer development: epithelial-cell–stromal-cell interactions and steroid hormone action in normal and cancerous mammary gland., Breast Cancer Res, 5, 208, 10.1186/bcr615 · DOI
  25. Gupta, 2007, Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers., Cancer Res, 67, 2062, 10.1158/0008-5472.CAN-06-3895 · DOI · Paper page
  26. Knight, 1977, Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer., Cancer Res, 37, 4669
  27. Pasic, 1990, Comparison of sex steroid receptor determinations in human breast cancer by enzyme immunoassay and radioligand binding., J Clin Lab Anal, 4, 430, 10.1002/(ISSN)1098-2825 · doi:10.1002/(issn)1098-2825
  28. Mascalzoni, 2015, International charter of principles for sharing bio-specimens and data., Eur J Hum Genet, 23, 721, 10.1038/ejhg.2014.197 · DOI · Paper page
  29. Kalpathy-Cramer, 2014, Quantitative imaging network: data sharing and competitive AlgorithmValidation leveraging the cancer imaging archive., Transl Oncol, 7, 147, 10.1593/tlo.13862 · DOI
  30. Gecer, 2018, Detection and classification of cancer in whole slide breast histopathology images using deep convolutional networks., Pattern Recognit, 84, 345, 10.1016/j.patcog.2018.07.022 · DOI · Paper page
  31. Cruz-Roa, 2018, High-throughput adaptive sampling for whole-slide histopathology image analysis (HASHI) via convolutional neural networks: application to invasive breast cancer detection., PLoS One, 13, e0196828, 10.1371/journal.pone.0196828 · DOI · Paper page

Cited by

See all 133

Metadata

Authors
Shamai, G., Binenbaum, Y., Slossberg, R., Duek, I., Gil, Z., & Kimmel, R.
Venue
JAMA Network Open
Published
2019-07-26
Volume
2
Issue
7
Pages
e197700
ISSN
2574-3805 (ISSN-L)
OpenAlex
W2964047652
Cited by
133
References
4
FWCI
6.91
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Artificial Intelligence Algorithms to Assess Hormonal Status From Tissue Microarrays in Patients With Breast Cancer. https://app.cochat.ai/papers/10.1001/jamanetworkopen.2019.7700
The paper
Shamai, G., Binenbaum, Y., Slossberg, R., Duek, I., Gil, Z., & Kimmel, R. (2019). Artificial Intelligence Algorithms to Assess Hormonal Status From Tissue Microarrays in Patients With Breast Cancer. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2019.7700

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.